Last reviewed · How we verify
NCT05755763
Validity and Reliability of the Turkish St. Marks Incontinence Score
trial testing Anal incontinence patients with St. Mark's Incontinence Score in Fecal Incontinence in 65 participants. Completed in 10 March 2023.
8 March 2023
Quick facts
| Lead sponsor | Atlas University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 65 |
| Start date | 7 February 2023 |
| Primary completion | 8 March 2023 |
| Estimated completion | 10 March 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Anal incontinence patients with St. Mark's Incontinence Score
Conditions studied
- Fecal Incontinence — all drugs for Fecal Incontinence →
- Pelvic Floor Disorders — all drugs for Pelvic Floor Disorders →
Sponsor
Atlas University
Who can join
18 and older, any sex, with Fecal Incontinence or Pelvic Floor Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
For the Turkish validity and reliability study of St.Mark's (Vaizey) Incontinence Score, which consists of 7 questions, it will be applied to 65 people diagnosed with anal incontinence after it is translated by translation-retranslation method.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Validity and Reliability of the Turkish St. Mark's Incontinence Score.
Ersoy Ö, Ecem Temel Y. · · 2026 · PMID 41942390 · DOI 10.5152/tjg.2026.25551
Verify or expand the search:
- PubMed search for NCT05755763
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Fecal Incontinence
Currently open trials in the same condition.
- NCT06532123 — Mechanisms of Improving Fecal Continence Muscles Motor Function · NA · recruiting
- NCT05998187 — Mechanisms of Action on Rectal Motricity of Intrarectal Botulinum Toxin Injections · Phase 3 · recruiting
- NCT06754189 — Safety and Performance of UCon Patch Electrode · NA · recruiting
- NCT06562140 — Multidimensional Examination of Patients with Colorectal and Anal Cancer · recruiting
- NCT06273046 — Treatment of Fecal Incontinence and Functional Evacuation Disorders Using Non-instrumental Biofeedback · NA · recruiting
Other Atlas University trials
Trials by the same sponsor.
- NCT07500129 — Tissue- and Serum-Derived Exosomal microRNAs as Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer · not yet recruiting
- NCT07509723 — Moulage Technique in Child Abuse Recognition · NA · not yet recruiting
- NCT07590245 — Comparative Effects of Sensorimotor Interventions on Hand Performance With Stroke · NA · completed
- NCT07348731 — Non-Pharmacological Methods in Heel Lance · NA · not yet recruiting
- NCT07435597 — Comparing the Effects of Art Therapy and Mandala Application on State Anxiety Levels in Chemotherapy Patients · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05755763 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Atlas University
- Last refreshed: 23 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05755763.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing